952182-76-2 Usage
Uses
Used in Organic Synthesis:
Ethyl 3-(trifluoromethyl)picolinate serves as a valuable building block in organic synthesis, contributing to the preparation of a wide array of pharmaceuticals, agrochemicals, and other fine chemicals. Its unique structural features make it an essential component in the creation of complex organic molecules.
Used in Pharmaceutical Development:
In the pharmaceutical industry, Ethyl 3-(trifluoromethyl)picolinate is utilized as a key intermediate for the synthesis of various drugs. Its incorporation into drug molecules can enhance their pharmacological properties, such as potency, selectivity, and bioavailability.
Used in Agrochemical Formulation:
Ethyl 3-(trifluoromethyl)picolinate also finds application in the agrochemical sector, where it is employed in the development of new insecticides. Its reported insecticidal activities make it a promising candidate for creating effective pest control agents that can protect crops and enhance agricultural productivity.
Used in Medicinal Chemistry Research:
The unique structure and properties of Ethyl 3-(trifluoromethyl)picolinate make it a valuable tool in medicinal chemistry research. It aids scientists in exploring new chemical spaces and discovering novel therapeutic agents with improved efficacy and selectivity against various diseases and conditions.
Check Digit Verification of cas no
The CAS Registry Mumber 952182-76-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,5,2,1,8 and 2 respectively; the second part has 2 digits, 7 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 952182-76:
(8*9)+(7*5)+(6*2)+(5*1)+(4*8)+(3*2)+(2*7)+(1*6)=182
182 % 10 = 2
So 952182-76-2 is a valid CAS Registry Number.
952182-76-2Relevant academic research and scientific papers
BETA ADRENERGIC AGONIST AND METHODS OF USING THE SAME
-
Paragraph 00291; 00292, (2020/10/18)
The present disclosure is directed to chemical compounds and to the use of such compounds in the treatment of diseases associated with an adrenergic receptor. In certain embodiments of the methods disclosed herein, the methods include administering to the subject a compound as disclosed herein and a peripherally acting P-blocker (PABRA).
NOVEL 5 OR 8-SUBSTITUTED IMIDAZO [1, 5-a] PYRIDINES AS INDOLEAMINE AND/OR TRYPTOPHANE 2, 3-DIOXYGENASES
-
Paragraph 0289, (2016/10/31)
Disclosed herein are 5 or 8-substituted imidazo[l,5-a]pyridines and pharmaceutical compositions comprising at least one such 5 or 8-substituted imidazo[l,5-a]pyridines, processes for the preparation thereof, and the use thereof in therapy. Disclosed herein are certain 5 or 8- substituted imidazo[l,5-a]pyridines that can be useful for inhibiting indoleamine 2,3- dioxygenase and/or tryptophane 2,3-dioxygenase and for treating diseases or disorders mediated thereby.
